Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Friedlander

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
Journal of Pediatric Gastroenterology and Nutrition|September 20, 2016
NASPGHAN Capsule Endoscopy Clinical ReportJoel A Friedlander, Quin Y Liu, Benjamin Sahn, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 24, 2020
Validation of a digital pathology system including remote review during the COVID-19 pandemicMatthew G Hanna, Victor E Reuter, Orly Ardon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2024
Cancer Immunotherapy Trials Network 12: Pembrolizumab in HIV-Associated Kaposi SarcomaKathryn Lurain, Ramya Ramaswami, Irene Ekwede, et al.
Journal for Immunotherapy of Cancer|April 21, 2021
Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinomaPaul Nghiem, Shailender Bhatia, Evan J Lipson, et al.
Journal for Immunotherapy of Cancer|July 25, 2025
Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumorsMohammed M Milhem, Trisha M Wise-Draper, Sunandana Chandra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2019
Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line TherapyPaul Nghiem, Shailender Bhatia, Evan J Lipson, et al.
The Journal of Investigative Dermatology|February 14, 2014
Dissection of immune gene networks in primary melanoma tumors critical for antitumor surveillance of patients with stage II-III resectable diseaseShanthi Sivendran, Rui Chang, Lisa Pham, et al.
The New England Journal of Medicine|April 20, 2016
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell CarcinomaPaul T Nghiem, Shailender Bhatia, Evan J Lipson, et al.
Pediatrics|February 14, 2018
Structure and Functions of Pediatric Aerodigestive Programs: A Consensus StatementR Paul Boesch, Karthik Balakrishnan, Sari Acra, et al.
Nature Cancer|February 5, 2022
Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsetsNina Bhardwaj, Philip A Friedlander, Anna C Pavlick, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Journal of Pediatric Gastroenterology and Nutrition|September 20, 2016
NASPGHAN Capsule Endoscopy Clinical ReportJoel A Friedlander, Quin Y Liu, Benjamin Sahn, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 24, 2020
Validation of a digital pathology system including remote review during the COVID-19 pandemicMatthew G Hanna, Victor E Reuter, Orly Ardon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2024
Cancer Immunotherapy Trials Network 12: Pembrolizumab in HIV-Associated Kaposi SarcomaKathryn Lurain, Ramya Ramaswami, Irene Ekwede, et al.
Journal for Immunotherapy of Cancer|April 21, 2021
Three-year survival, correlates and salvage therapies in patients receiving first-line pembrolizumab for advanced Merkel cell carcinomaPaul Nghiem, Shailender Bhatia, Evan J Lipson, et al.
Journal for Immunotherapy of Cancer|July 25, 2025
Phase 1b/2 study evaluating safety, efficacy and immune effects of TLR9 agonist cavrotolimod with anti-PD-1 antibodies among patients with advanced solid tumorsMohammed M Milhem, Trisha M Wise-Draper, Sunandana Chandra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2019
Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line TherapyPaul Nghiem, Shailender Bhatia, Evan J Lipson, et al.
The Journal of Investigative Dermatology|February 14, 2014
Dissection of immune gene networks in primary melanoma tumors critical for antitumor surveillance of patients with stage II-III resectable diseaseShanthi Sivendran, Rui Chang, Lisa Pham, et al.
The New England Journal of Medicine|April 20, 2016
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell CarcinomaPaul T Nghiem, Shailender Bhatia, Evan J Lipson, et al.
Pediatrics|February 14, 2018
Structure and Functions of Pediatric Aerodigestive Programs: A Consensus StatementR Paul Boesch, Karthik Balakrishnan, Sari Acra, et al.
Nature Cancer|February 5, 2022
Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsetsNina Bhardwaj, Philip A Friedlander, Anna C Pavlick, et al.
Pageof 13